BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 15262129)

  • 1. Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer.
    Dubay RA; Rose PG; O'Malley DM; Shalodi AD; Ludin A; Selim MA
    Gynecol Oncol; 2004 Jul; 94(1):121-4. PubMed ID: 15262129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcomes of concurrent weekly carboplatin with radiation therapy in locally advanced cervical cancer patients.
    Katanyoo K; Tangjitgamol S; Chongthanakorn M; Tantivatana T; Manusirivithaya S; Rongsriyam K; Cholpaisal A
    Gynecol Oncol; 2011 Dec; 123(3):571-6. PubMed ID: 21955483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study.
    Muderspach LI; Curtin JP; Roman LD; Gebhardt JA; Klement V; Qian D; Morrow CP; Felix JC; Formenti SC; Muggia FM
    Gynecol Oncol; 1997 May; 65(2):336-42. PubMed ID: 9159348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
    Serkies K; Jassem J
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].
    Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix.
    Lee MY; Wu HG; Kim K; Ha SW; Kim JS; Kim IA; Lee HP
    Gynecol Oncol; 2007 Jan; 104(1):95-9. PubMed ID: 16996117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized phase III trial of concurrent chemoradiotherapy in locally advanced cervical cancer: preliminary results.
    Veerasarn V; Lorvidhaya V; Kamnerdsupaphon P; Suntornpong N; Sangruchi S; Lertsanguansinchai P; Khorprasert C; Sookpreedee L; Udompunturak S
    Gynecol Oncol; 2007 Jan; 104(1):15-23. PubMed ID: 16996583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
    Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
    Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience.
    Tinker AV; Bhagat K; Swenerton KD; Hoskins PJ
    Gynecol Oncol; 2005 Jul; 98(1):54-8. PubMed ID: 15904950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent radiotherapy, paclitaxel and dose escalating carboplatin in the treatment of cervical cancer--a phase I study.
    Addeo D; Blank S; Muggia F; Formenti S
    Anticancer Res; 2008; 28(5B):3143-6. PubMed ID: 19031972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel and carboplatin concurrent with radiotherapy for primary cervical cancer.
    de Vos FY; Bos AM; Gietema JA; Pras E; Van der Zee AG; de Vries EG; Willemse PH
    Anticancer Res; 2004; 24(1):345-8. PubMed ID: 15015619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
    Rose PG; Ali S; Watkins E; Thigpen JT; Deppe G; Clarke-Pearson DL; Insalaco S;
    J Clin Oncol; 2007 Jul; 25(19):2804-10. PubMed ID: 17502627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancer.
    Richel O; Zum Vörde Sive Vörding PJ; Rietbroek R; Van der Velden J; Van Dijk JD; Schilthuis MS; Westermann AM
    Gynecol Oncol; 2004 Dec; 95(3):680-5. PubMed ID: 15581981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer.
    Downs LS; Judson PL; Argenta PA; Carson LF; Boente MP
    Gynecol Oncol; 2004 Nov; 95(2):347-51. PubMed ID: 15491756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer.
    Miglietta L; Franzone P; Centurioni MG; Boni L; Tacchini L; Cosso M; Boccardo F; Ferrarini M; Bruzzone M
    Oncology; 2006; 70(1):19-24. PubMed ID: 16439862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.